The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Open accessAbstract
Hemophagocytic syndrome (HPS) is characterized by an uncontrolled and poorly understood activation of T-helper 1 (Th-1) lymphocytes and macrophages. We studied 20 patients with HPS secondary to infections, autoimmune disease, lymphoma, or cancer and observed that the concentrations of serum interleukin 18 (IL-18), a strong inducer of Th-1 responses, interferon gamma (IFN-gamma) production, and stimulation of macrophages and natural killer (NK) cells were highly increased in HPS but not in control patients. In contrast, concentrations of its natural inhibitor, the IL-18 binding protein (IL-18BP), were only moderately elevated, resulting in a high level of biologically active free IL-18 in HPS (4.6-fold increase compared with controls; P < .001). Free IL-18 but not IL-12 concentrations significantly correlated with clinical status and the biologic markers of HPS such as anemia (P < .001), hypertriglyceridemia, and hyperferritinemia (P < .01) and also with markers of Th-1 lymphocyte or macrophage activation, such as elevated concentrations of IFN-gamma and soluble IL-2 and tumor necrosis factor alpha (TNF-alpha) receptor concentrations. Despite high IL-18 elevation, in vitro NK-cell cytotoxicity was severely impaired in HPS patients, in part due to NK-cell lymphopenia that was observed in a majority of patients but also secondary to an intrinsic NK-cell functional deficiency. We concluded that a severe IL-18/IL-18BP imbalance results in Th-1 lymphocyte and macrophage activation, which escapes control by NK-cell cytotoxicity and may allow for secondary HPS in patients with underlying diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with cytokine storm due to macrophage activation syndrome have high levels of interleukin-18 in serum,44”
From Cytokine storm (2020) · cites this paper as [44]
In the citing paper
“The ratio of free interleukin-18 to bound interleukin-18–IL18BP complexes in serum is an important indicator of the severity of the macrophage activation syndrome.44,47”
From Cytokine storm (2020) · cites this paper as [44]
Citations
Cites
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,319
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Dogniaux, S., Mathew, P. A., Henter, J., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,236
Risdall, R. J., McKenna, R. W., Nesbit, M. E., Krivit, W. A., Balfour, H. H., Simmons, R. L., & Brunning, R. D. (1979) · Cancer · doi:10.1002/1097-0142(197909)44:3 · Cited by 1,037
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
Ménasché, G., Pastural, É., Feldmann, J., Dogniaux, S., Ersoy, F., Dupuis, S., Wulffraat, N. M., Bianchi, D. W., Fischer, A., Deist, F. L., et al. (2000) · Nature Genetics · doi:10.1038/76024 · Cited by 957
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 817
Interleukin-18 Binding Protein
Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 781
Henter, J., Elinder, G., & Öst, Å. (1991) · PubMed · Cited by 762
Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood · doi:10.1182/blood-2003-10-3413 · Cited by 712
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P. L., Greer, M. R., Kennedy, K., Carter, R., Wei, X., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 635
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E. F., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 573
Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S. S., & Dinarello, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1379 · Cited by 545
Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease
Fautrel, B., Zing, E., Golmard, J., Moël, G. L., Bissery, A., Rioux, C., Rozenberg, S., Pietté, J. C., & Bourgeois, P. (2002) · Medicine · doi:10.1097/00005792-200205000-00003 · Cited by 514
Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
Henter, J., Elinder, G., Soder, O., Hansson, M., Andersson, B., & Andersson, U. (1991) · Blood · doi:10.1182/blood.v78.11.2918.2918 · Cited by 505
Costello, R. T., Sivori, S., Marcenaro, E., Lafage‐Pochitaloff, M., Mozziconacci, J., Reviron, D., Gastaut, J., Pende, D., Olive, D., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.10.3661 · Cited by 499
INFECTION- AND MALIGNANCY-ASSOCIATED HEMOPHAGOCYTIC SYNDROMES
Janka, G., Imashuku, S., Elinder, G., Schneider, M., & Henter, J. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70521-9 · Cited by 451
Puren, A. J., Fantuzzi, G., & Dinarello, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2256 · Cited by 379
Cytokine Production Regulating Th1 and Th2 Cytokines in Hemophagocytic Lymphohistiocytosis
Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., et al. (1997) · Blood · doi:10.1182/blood.v89.11.4100 · Cited by 366
Macrophage activation syndrome
Ravelli, A. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00012 · Cited by 335
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
Reyburn, H. T., Mandelboim, O., Valés‐Gómez, M., Davis, D. M., Pazmany, L., & Strominger, J. L. (1997) · Nature · doi:10.1038/386514a0 · Cited by 320
Dhôte, R., Simon, J., Papo, T., Detournay, B., Sailler, L., Andre, M., Dupond, J. L., Larroche, C., Piette, A., Mechenstock, D., et al. (2003) · Arthritis Care & Research · doi:10.1002/art.11368 · Cited by 320
Grom, A. A., Villanueva, J. M., Lee, S., Goldmuntz, E. A., Passo, M. H., & Filipovich, A. H. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.110 · Cited by 284
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Henter, J., Aricò, M., Elinder, G., Imashuku, S., & Janka, G. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70520-7 · Cited by 282
A NOVEL IL-18BP ELISA SHOWS ELEVATED SERUM IL-18BP IN SEPSIS AND EXTENSIVE DECREASE OF FREE IL-18
Novick, D., Schwartsburd, B. I., Pinkus, R., Suissa, D., Belzer, I., Sthoeger, Z. M., Keane, W. F., Chvatchko, Y., Kim, S. H., Fantuzzi, G., et al. (2001) · Cytokine · doi:10.1006/cyto.2001.0914 · Cited by 278
Imashuku (1997) · International Journal of Hematology · doi:10.1016/s0925-5710(97)00584-7 · Cited by 265
Hyodo, Y., Matsui, K., Hayashi, N., Tsutsui, H., Kashiwamura, S., Yamauchi, H., Hiroishi, K., Takeda, K., Tagawa, Y., Iwakura, Y., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1662 · Cited by 233
Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes
Komp, D., McNamara, J., & Buckley, P. J. (1989) · Blood · doi:10.1182/blood.v73.8.2128.bloodjournal7382128 · Cited by 227
Calculation of lytic units for the expression of cell-mediated cytotoxicity
Bryant, J., Day, R., Whiteside, T. L., & Herberman, R. B. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90052-u · Cited by 221
Pathogenesis of hemophagocytic syndrome (HPS)
Larroche, C., & Mouthon, L. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00091-0 · Cited by 220
Macrophage Activation Syndrome
Ravelli, A., Davì, S., Minoia, F., Martini, A., & Cron, R. Q. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.010 · Cited by 211
Bacteria-associated hemophagocytic syndrome
Risdall, R. J., Brunning, R. D., Hernandez, J. I., & Gordon, D. (1984) · Cancer · doi:10.1002/1097-0142(19841215)54:12 · Cited by 186
Reddy, P. R., Teshima, T., KuKuruga, M. A., Ordemann, R., Liu, C., Lowler, K., & Ferrara, J. L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1433 · Cited by 170
Schneider, E. M., Lorenz, I., Müller-Rosenberger, M., Steinbach, G., Kron, M., & Janka-Schaub, G. E. (2002) · Blood · doi:10.1182/blood-2001-12-0260 · Cited by 158
Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?
Grom, A. A. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200309000-00011 · Cited by 150
Henter, J., Tondini, C. A., & Pritchard, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.01.002 · Cited by 149
Wildbaum, G., Youssef, S., Grabie, N., & Karin, N. (1998) · PubMed · Cited by 144
Impaired natural killer activity in lymphohistiocytosis syndrome
Perez, N., Virelizier, J.-L., Arenzana-Seisdedos, F., Fischer, A., & Griscelli, C. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80549-1 · Cited by 121
Oversecretion of IL‐18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity
Takada, H., Ohga, S., Mizuno, Y., Suminoe, A., Matsuzaki, A., Ihara, K., Kinukawa, N., Ohshima, K., Kohno, K., Kurimoto, M., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01504.x · Cited by 114
Maeno, N., Takei, S., Nomura, Y., Imanaka, H., Hokonohara, M., & Miyata, K. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10389 · Cited by 98
Maeno, N., Takei, S., Imanaka, H., Yamamoto, K., Kuriwaki, K., Kawano, Y., & Oda, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20268 · Cited by 91
Barrat, F. J., Deist, F. L., Benkerrou, M., Bousso, P., Feldmann, J., Fischer, A., & Basile, G. D. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8645 · Cited by 81
The role of cytotoxicity in lymphocyte homeostasis
Basile, G. D. S., & Fischer, A. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00257-0 · Cited by 79
Adult onset Still's disease associated hemophagocytosis.
Kumakura, S., Ishikura, H., Munemasa, S., Adachi, T., Murakawa, Y., & Kobayashi, S. (1997) · PubMed · Cited by 70
Interleukin-18 in Hemophagocytic Lymphohistiocytosis
Takada, H., Nomura, A., Ohga, S., & Hara, T. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097673 · Cited by 63
Stepp, S. E., Dufourcq-Lagelouse, R., & Kumar, V. (2015) · PubMed · Cited by 59
Serum IL-18 levels in patients with various hematological disorders
Takubo, T., Kumura, T., Ohta, K., Tatsumi, N., Ohkura, H., Hino, M., Yamane, T., & Kamitani, T. (2000) · Haematologia · doi:10.1163/15685590051129850 · Cited by 10
Expression of host defense scavenger receptors in spondylarthropathy
McBeth (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200104)44:4 · Cited by 1
Straub, R. H., & Cutolo, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3
Cited by
Sorted by citations
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,812
Adult haemophagocytic syndrome
Ramos‐Casals, M., Brito‐Zerón, P., López‐Guillermo, A., Khamashta, M. A., & Bosch, X. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,445
Metadata
- Authors
- Mazodier, K.
- Affiliations
- Inserm (FR)
- Corresponding author
- Mazodier, K.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2005-11-15
- Volume
- 106
- Issue
- 10
- Pages
- 3483-3489
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1895045
- OpenAlex
- W2157675757
- Cited by
- 290
- References
- 47
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 19 · 2023: 16 · 2022: 16 · 2021: 17 · 2020: 13 · 2019: 19 · 2018: 19 · 2017: 18 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 13 · 2012: 12
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL68743, P01HL068743)
- National Institute of Allergy and Infectious Diseases (AI‑15614)
- Topics
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
- Keywords
- hemophagocytic lymphohistiocytosis, secondary hemophagocytic lymphohistiocytosis, IL-18, IL-18BP, macrophage activation, interferon-gamma, NK cell cytotoxicity, hyperferritinemia, hypertriglyceridemia, anemia, soluble interleukin-2 receptor, TNF-alpha receptor, cytokine imbalance
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Autoimmune Diseases, Female, Glycoproteins, Humans, Leukocytes, Lymphocyte Activation, Lymphopenia, Macrophage Activation, Male, Middle Aged, Neoplasms, Prospective Studies, Biomarkers, Cytokines, Interleukin-18, Intercellular Signaling Peptides and Proteins, Lymphohistiocytosis, Hemophagocytic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review